Manuscripts

Search by keyword, year, or author name.

Showing 1591 manuscripts.

Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial

Bruce R. Schackman, Ph.D., Callie A. Scott, B.A., Paul Edward Sax, M.D., Elena Losina, Timothy J. Wilkin, M.D., M.P.H., John Ernest McKinnon, M.D., Susan Swindells, M.B.B.S., Milton C. Weinstein, Kenneth A. Freedberg, M.D., M.Sc. Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial. Clinical Infectious Diseases. 2007 Oct 15; 45(8):1062-70.

Year

2007

Journal

Clinical Infectious Diseases

Lipids and lactate in human immunodeficiency virus-1-infected pregnancies with or without protease inhibitor-based therapy

Elizabeth Livingston, M.D., Susan Ellen Cohn, M.D., M.P.H., Yang Yang, Ph.D., Heather D. Watts, M.D., Arlene D. Bardeguez, M.D., M.P.H., F.A.C.O.G., Theodore Benjamin Jones, M.D., F.A.C.O.G., Laura M. Smith, M.P.H., Triin Umbleja, M.Sc., Grace McComsey, M.D. Lipids and lactate in human immunodeficiency virus-1-infected pregnancies with or without protease inhibitor-based therapy. Obstetrics and Gynecology. 2007 Aug 01; 110(2: Part 1):391-7.

Year

2007

Journal

Obstetrics and Gynecology

Data monitoring in clinical trials using prediction

Scott Evans, Ph.D., Li-Fang Li, Lee-Jen Wei, Ph.D. Data monitoring in clinical trials using prediction. Drug Information Journal. 2007 Nov 01; 41(6).

Year

2007

Journal

Drug Information Journal

HIV coinfection impairs CD28-mediated costimulation of hepatitis C virus-specific CD8 cells

Nicole L. Yonkers, Benigno Rodriguez, M.D., Anthony B. Post, Robert Asaad, M.D., Linda Jones, R.N., Michael M. Lederman, M.D., Paul V. Lehmann, Donald D. Anthony, M.D., Ph.D. HIV coinfection impairs CD28-mediated costimulation of hepatitis C virus-specific CD8 cells. Journal of Infectious Diseases. 2007 Jul 20; 194(3):391-400.

Year

2007

Journal

Journal of Infectious Diseases

TLR9 stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function

Wei Jiang, M.D., M.S., Michael M. Lederman, M.D., Clifford V. Harding, Benigno Rodriguez, M.D., Richard Mohner, B.S., Scott F. Sieg, Ph.D. TLR9 stimulation drives naive B cells to proliferate and to attain enhanced antigen presenting function. European Journal of Immunology. 2007 Aug 01; 37(8):2205-13.

Year

2007

Journal

European Journal of Immunology

Challenges in using observational studies to evaluate adverse effects of treatment

Michael Hughes, Ph.D., Paige L. Williams, Ph.D. Challenges in using observational studies to evaluate adverse effects of treatment. New England Journal of Medicine. 2007 Apr 26; 356(17):1705-7.

Year

2007

Journal

New England Journal of Medicine

Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD)

Stephen J. Gange, Mari M. Kitahata, M.D., M.P.H., Michael Switow Saag, M.D., D. R. Bangsberg, Ronald J. Bosch, Ph.D., John Brooks, Steven G. Deeks, M.D., Joseph J. Eron, Jr., M.D., Liviana M. Calzavara, M. John Gill, David W. Haas, M.D., Kelly A. Gebo, Michael Horberg, Robert S. Hogg, Amy C. Justice, M.D.,Ph.D., Lisa P. Jacobson, Marina B. Klein, M.D., C.M., M.Sc., Jeffrey N. Martin, Gregory D. Kirk, Benigno Rodriguez, M.D., Rosemary G. McKaig, M.P.H., Ph.D., Timothy R. Sterling, M.D., M.P.H., Sean B. Rourke, Aimee M. Freeman, Richard D. Moore. Cohort profile: the North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD). International Journal of Epidemiology. 2007 Apr 01; 36(2):294-301.

Year

2007

Journal

International Journal of Epidemiology

Comparative efficacy of nucleoside/nucleotide reverse transcriptase inhibitors in combination with efavirenz: results of a systematic overview

John Alexander Bartlett, M.D., S. H. Chen, M.D., Joseph Quinn, R.N. Comparative efficacy of nucleoside/nucleotide reverse transcriptase inhibitors in combination with efavirenz: results of a systematic overview. HIV Clinical Trials. 2007 Jul 01; 8(4):221-6.

Year

2007

Journal

HIV Clinical Trials

Childhood abuse and initial presentation for HIV care: an opportunity for early intervention

Michael J. Mugavero, M.D., M.H.S., Brian Wells Pence, Ph.D., Kathryn Whetten, Ph.D., M.P.H., Jane Leserman, Ph.D., Marvin Swartz, M.D., Dalene Stangl, Ph.D., Nathan Thielman, M.D., M.P.H. Childhood abuse and initial presentation for HIV care: an opportunity for early intervention. AIDS Care. 2007 Oct 01; 19(9):1083-7.

Year

2007

Journal

AIDS Care

Defining HIV susceptibility to new antiretroviral agents- darunavir

Richard H. Haubrich, M.D. Defining HIV susceptibility to new antiretroviral agents- darunavir. Journal of Infectious Diseases. 2007 Oct 15; 196(8):1125-7.

Year

2007

Journal

Journal of Infectious Diseases